1 / 14

Joint Presentation by: Immunization Services Division

Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Planning for Seasonal Influenza Pilot Test as Proxy Using CDC's Countermeasure and Response Administration System. Webinar Presentation to Public Health Project Areas June 27, 2007. Joint Presentation by:

jeb
Download Presentation

Joint Presentation by: Immunization Services Division

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Planning for Seasonal Influenza Pilot Test as Proxy Using CDC's Countermeasure and Response Administration System Webinar Presentation to Public Health Project Areas June 27, 2007 Joint Presentation by: Immunization Services Division National Center for Immunization and Respiratory Diseases and Division of Emergency Preparedness and Response National Center for Public Health Informatics

  2. Learning Objectives • Understand the importance of the seasonal influenza pilot test as a proxy for pandemic influenza vaccine usage tracking • Understand the data expected and frequency for the pilot • Understand the expected benefits or lessons learned from the pilot • Understand the expected challenges for the pilot • Understand the CDC technical support available for preparing for pilot testing

  3. Background • In the event of an influenza pandemic, timely and complete reporting of Pandemic Influenza vaccine doses administered will allow the Federal Government and Project Areas to closely monitor the use of the vaccine while it is in scarce supply • CDC and the Project Areas are planning to use a small number of seasonal influenza clinics as proxies for pandemic influenza vaccine administration sites to evaluate technical systems for monitoring pandemic influenza vaccine doses administered

  4. Background (continued) • Project Areas will be assessed on their ability to collect and report to CDC on vaccine doses administered • CDC will assess the technical capability of the CRA system to receive and aggregate Project Area data • The goal is to conduct this exercise with minimally invasive impact to normal operations • This pilot will involve submission of a minimal number of data elements to CDC

  5. Why is the Pilot Testing Needed? An Operational Perspective • To assess ability to collect and report vaccine doses administered data • To provide perspective on federal, Project Area and clinic needs in order to scale-up for a pandemic situation • Initial attempt to exercise vaccine tracking plans • Accomplish timely reporting between key parties

  6. Why is the Pilot Testing Needed?A Technical Perspective • To assess the technical ability of systems to receive, aggregate, and return data • To identify and address system gaps • To test tooling options and security aspects for federal and state partners

  7. Data Expected by CDC From the Project Area • Will include (required) • Age • Project Area ID • Date of Clinic(s) • Will NOT include • Priority Group • Dose Number

  8. Reporting Frequency and Timeframe • Number of Reports and Frequency • If only one clinic site is being used, data from at least two clinic sessions should be reported using two distinct transmissions • If more than one clinic site is being used, data from at least one session for each site should be reported using a distinct transmission for each site • Time Frame • Clinic sessions should occur between November 1 and December 31, 2007 • Data from each clinic should be compiled and transmitted within 48 hours of the clinic session

  9. Expected Benefits or Lessons Learned • Provide a framework for developing future pandemic influenza reporting plans • Illustrate technical gaps and needs • Identify operational barriers • Understand training needs of staff • Identify equipment needs and capabilities • Gain a preliminary understanding of costs and other impacts to clinical operations

  10. Expected Challenges for Project Area • Communication and support among all parties • Availability/distribution of seasonal vaccine • Technical glitches; training and equipment needs • Clinic selection and scheduling • Timeliness and completeness of reporting

  11. Expected Challenges for Clinics • Availability of seasonal vaccine • Reporting not currently required • Timeliness and completeness of reporting • Data entry staffing, training, and equipment needs • Communication and support

  12. Points of Contact and Resources • Toscha Stanley, Immunization Services Division (ISD),tstanley@cdc.gov • All POCs have been submitted!!! THANK YOU • Sanjeeb Sapkota, CRA Team, Division of Emergency Preparedness and Response, ssapkota@cdc.gov or CRAHelp@cdc.gov • Submit option choice by June 30 • CRA Help E-mail CRAHelp@cdc.gov • General aggregate reporting questions and inquiries • Getting access to CRA Exchange, an interactive knowledge sharing and exchange web site (http://team.cdc.gov/) • PHIN E-mail PHINTech@cdc.gov • Issuing digital certificates • Getting access to CRA demonstration site • Problem solving • To get a copy of all presentations and Q and A’s from presentations: http://www.cdc.gov/phin/preparedness/cra.html

  13. Questions?Questions may also be emailed to: CRAHelp@cdc.gov

  14. Webinar and Meeting Schedule • July TBD: Open Q&A and updates on options and pilot test • August TBD: Open Q&A and updates on options and pilot test

More Related